Latest News Archive

Please select Category, Year, and then Month to display items

UFS drops wearing of masks on campus

23 June 2022 | Story Lacea Loader

The management of the University of the Free State (UFS) has taken note of the announcement by the Minister of Health, Dr Joe Phaahla, in the Government Gazette on 22 June 2022, in which COVID-19 regulations were repealed.

Minister Phaahla stated that, as from 22 June, South Africans no longer have to wear masks, and that limits on gatherings and border checks for COVID-19, as well as the need to be vaccinated in order to enter South Africa, have also been dropped.

The UFS COVID-19 Regulations and Required Vaccination Policy has created an environment that the university management regards as safe. This, together with yesterday’s announcement by the Minister, was considered, and a decision was made that the wearing of masks on campus or in any building on campus is no longer compulsory.

However, the UFS COVID-19 Regulations and Required Vaccination Policy remains in place. Campus access control is still in place, and staff, students, and visitors are expected to upload a COVID-19 vaccination certificate or a negative PCR or antigen test result to obtain access to the campuses.

The wearing of masks is still recommended and will be of value especially in the following instances:

1. For immune-compromised staff, students, and visitors
2. For persons who are ill with, e.g., flu, colds, coughs, etc.

In the case of staff and students working in public and private hospitals, or any other external laboratory/facility, the wearing of masks is determined by the hospital or the external laboratory/facility and not by the UFS. In any other environment where students or staff are under the regulations of external organisations, these regulations will take precedence.

Staff and students are encouraged to feel free to continue wearing masks, including those with comorbidities, as masks have been shown to be helpful in preventing the spread of respiratory diseases. Good health-care behaviour remains important as COVID-19 is still a reality.

The university management will decide in due course on the possible upliftment of restrictions on public gatherings.

Released by:
Lacea Loader (Director: Communication and Marketing)
Telephone: +27 51 401 2584 | +27 83 645 2454
Email: news@ufs.ac.za | loaderl@ufs.ac.za

News Archive

Researchers receive study grant for research into Congo Fever

2015-03-10

UFS researchers will be contributing significantly to the search for a vaccine against the deadly tick-borne disease known as Congo Fever.

Prof Felicity Burt from the Department of Medical Microbiology and Virology was recently awarded a research grant by the National Health Laboratory Service (NHLS) to study candidate vaccines for Crimean-Congo heamorrhagic fever (CCHF) virus and other arboviruses.

Arboviruses are viruses transmitted by mosquitoes, ticks, or other arthropods.

Prof Burt is an internationally-recognised expert on the Crimean-Congo haemorrhagic fever (CCHF). The Crimean-Congo haemorrhagic fever (CCHF) virus is a tick-borne virus that is associated with severe haemorrhagic disease in South Africa and other parts of Africa, Asia, and eastern Europe. Her interests focus on medically significant viruses that are transmitted by ticks and mosquitoes. Her research group is involved in determining the immune responses that are induced by different viral proteins.

Crimean-Congo haemorrhagic fever (CCHF) virus, a tick- borne virus found in Africa, Asia, the Balkans, and eastern Europe, causes severe viral haemorrhagic fever outbreaks.

Although a number of tick species are capable of becoming infected with CCHF virus, ticks of the genus Hyalomma, commonly referred to in SA as the “bont-legged ticks”, are the principal vector. The ticks have distinctive brown and white bands on their legs.

In February 1981, the first case of CCHF was recognised in South Africa (SA). To date, there have been nearly 200 cases of CCHF infection in SA with a 20% fatality rate. The majority of cases occurring in SA were in patients from the Northern Cape and Free State provinces.

“The funding that has been awarded will be used to profile immune responses against CCHF viral proteins, and investigate mechanisms and strategies to enhance these immune responses. We hope that the study will contribute knowledge towards the development of a vaccine against this medically significant virus.”

For more information or enquiries contact news@ufs.ac.za.

Back

Economic and Management Sciences

Education

Health Sciences

The Humanities

Law

Natural and Agricultural Sciences

Theology and Religion

Open Distance Learning

Business School

We use cookies to make interactions with our websites and services easy and meaningful. To better understand how they are used, read more about the UFS cookie policy. By continuing to use this site you are giving us your consent to do this.

Accept